NOTES "Now we're facing another sizeable reduction for drugs worth 20% of the market and this is a matter of great concern for pharmacists in the province, " says Paul Blanchard, Executive Director of the New Brunswick Pharmacists' Association. "We have had significant devaluation of pricing in a very short period of time and we've had little government support to help us modify our business model. "
Saskatchewan pharmacists welcome commitment to reinvestment
Saskatchewan's premier Brad Wall is the only leader to have clearly committed to using some of its generic drug savings to fund pharmacy services.
This was welcome news to the Pharmacists' Association of Saskatchewan (PAS), which was in the midst of contract negotiations with the provincial government.
"The Minister of Health actually wrote a letter to each individual pharmacy in the province, saying the government is very committed to pharmacist services in the health system and that they were looking to re-invest," says Dawn Martin, PAS executive director. "But we too are concerned to see that many other provinces aren't taking a similar approach. This is a shaking of the foundations of the profession, with rapid changes in revenue and expense models that have been formed over the last 30 years.
"Governments need to ensure that pharmacists are available in the system to provide important health services and if you shake the foundational revenue model, you are risking that, " she adds.
Governments reject competitive tendering
In July 2012, when the provinces and territories revealed plans to collaborate more closely on generic price reductions, they put forward the idea of a national competitive bidding process. Ultimately, they rejected that idea and opted for the pricing agreement instead.
That shift was welcomed by pharmacy representatives, including Jim Keon, president of the CGPA. "Tendering for generic drugs could result in drug shortages and delayed savings to Canada's health care system, " Keon said in a January 18 news release.
Meanwhile, the provinces and territories say more generic price reductions are on the horizon, and pharmacy stakeholders are attempting to work more closely with government to manage the impact of future changes.
"In the short term, we're going to continue to argue for re-investment in pharmacy services, " says Mr. Morrison of the CPhA. "And for the longer term, governments have agreed to look at more predictable policies on pricing and pharmacy-related services.
"What's been happening over the past couple of years is we are getting these pricing changes with little notice, " he says. "It's been very difficult for pharmacies to plan ahead when they don't know a year out what sort of prices they are going to be facing. " DOI: 10.1177/1715163513482704 Pharmacist prescribing for minor ailments could significantly relieve pressure on ERs, say New Brunswick pharmacists A uthorizing pharmacists to prescribe for minor ailments could help lower high numbers of non-urgent visits to New Brunswick emergency rooms, according to the New Brunswick Pharmacists' Association (NBPA).
More than 63% of patients visiting hospital ERs in 2011−12 had triage levels of "nonurgent" or "less urgent," the New Brunswick Health Council revealed in its latest annual report. In recent meetings with the province's Health Minister, Ted Flemming, the NBPA has pointed to this data as further evidence that minor-ailment prescribing authority for pharmacists would benefit patients and the broader health care system. "We don't know specifically how many of these non-urgent ER visits involve minor ailments, but we know anecdotally that we are talking about a significant percentage," says Paul Blanchard, Executive Director of the NBPA. "New Brunswick pharmacists are qualified to provide the type of service that will divert some patients from over-burdened ERs and after-hours clinics."
The province's Health Council measures patients' interactions with the health care system in terms of visits to physicians, clinics and hospitals, and also reports on waiting times for surgeries and medical tests. The Council, however, does not currently measure how many people with minor ailments head to their community pharmacy to seek advice and appropriate treatment, says Mr. Blanchard.
"If people have a minor health problem, the first thing they try to do is self-treat and the first place they go in order to do that is a pharmacy, where they can talk to a pharmacist without an appointment."
Giving pharmacists the authority to write prescriptions in these cases would eliminate the need for many of these patients to go elsewhere to get treatment, he adds.
The New Brunswick Pharmaceutical Society has developed the Draft Pharmacy Act, October 2012, which proposes pharmacist prescribing for a range of minor ailments, along with other changes including regulation of pharmacy technicians. The Society is consulting health professionals on the proposals and the provincial government is also reviewing the draft legislation.
The NBPA is advocating for approval of these minor-ailment measures, as well reimbursement of pharmacists providing the service. The association points to Saskatchewan as the best model, where pharmacists are compensated for prescribing treatments for ailments ranging from allergic reactions and insect bites to diaper rash and cold sores. Pharmacists in Nova Scotia recently acquired this prescribing authority as well.
"If people have a minor health problem, the first thing they try to do is selftreat and the first place they go in order to do that is a pharmacy" -Paul Blanchard, Executive Director, New Brunswick Pharmacists' Association Canadian research finds automated calling system helps identify adverse drug reactions U sing automated phone calls to follow up with patients after they receive a prescription can help uncover adverse drug events (ADEs), according to new Canadian research.
The study, published in the online version of JAMA Internal Medicine on February 4, 2013, was led by Alan Forster, Scientific Director of Performance Measurement at Ottawa Hospital. According to Dr. Forster, the study was the first to use an automated calling system to check for adverse drug reactions.
The research involved 629 patients at family health care practices in Quebec. The patients were contacted 3 days after receiving their prescription medication and again after 17 days, and responded to recorded questions that asked them about problems or new symptoms that had occurred after beginning to take the drug. Study researchers then contacted the patients after 21 days to get more detailed information.
The study found that the automated phone call system identified 58 out of 125 ADEs (46%). The system offered the patients the chance to receive a phone call from a pharmacist to have a further discussion about their medication; about one-third of the patients asked for such a call.
A journal editorial accompanying the study called the findings promising, but noted that automated calls alone have limitations, given that slightly fewer than half of ADEs were identified.
The Canadian Institutes of Health Research (CIHR) is funding a randomized control trial of the system to gather more information on potential benefits and cost-effectiveness. DOI: 10.1177/1715163513482709
